Liquidia (LQDA) Property, Plant & Equipment (Net) (2019 - 2026)
Powered by 
Analysis
Liquidia (LQDA) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 1.93 Bn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 34.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.56 Mn |
| Mar 31, 2026 | 20.84 Mn |
| Dec 31, 2025 | 11.84 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 9.54 Mn |
| Mar 31, 2025 | 8.48 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 7.78 Mn |
| Jun 30, 2024 | 6.39 Mn |
| Mar 31, 2024 | 5.58 Mn |
| Dec 31, 2023 | 4.48 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 4.35 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | 4.22 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 5.02 Mn |
| Sep 30, 2021 | 5.45 Mn |